EXPLORING THE TRANSFORMATIVE POTENTIAL OF PERSONALIZED METABOLOMICS IN OSTEOGENESIS IMPERFECTA
DOI:
https://doi.org/10.51891/rease.v10i1.13024Keywords:
Osteogenesis Imperfecta. Metabolomics. Collagen. Biomarkers.Abstract
The scientific article addresses the importance of metabolomics as an essential tool in biomedical research, highlighting its role in expanding molecular knowledge of diseases and advancing personalized medicine. Personalized metabolomics is recognized for its significant potential in improving healthcare by identifying biomarkers, therapeutic targets, and understanding variations in drug response and metabolism. The study emphasizes the relevance of metabolomics in biomedical research, especially in the context of Osteogenesis Imperfecta (OI). Recognizing the capability of personalized metabolomics to enhance molecular understanding of OI by identifying specific metabolites, potential biomarkers, and therapeutic targets for this rare genetic condition, the study also underscores the need to overcome challenges such as standardizing protocols and the complexity of data analysis. It emphasizes the importance of collaboration among scientists, medical professionals, and patients to translate these findings into effective clinical practices for managing OI.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Atribuição CC BY